Clinical trial
The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients
NCT00247507 is registered in ClinicalTrials.gov with Far Eastern Memorial Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients
- Lead sponsor
- Far Eastern Memorial Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- September 30, 2005
- Completion date
- December 31, 2005
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anemia, atherosclerosis, end-stage renal disease, oxidative stress, pro-inflammation